@ARTICLE{
author={Hart Lowell L,Ferrarotto Renata,Andric Zoran G,Beck Thaddeus J,Subramanian Janakiraman,Radosavljevic Davorin Z,Zaric Bojan,Hanna Wahid T,Aljumaily Raid,Owonikoko Taofeek K,Verhoeven Didier,Xiao Jie,Morris Shannon R,Antal Joyce M,Hussein Maen A},
year={2021},
title={Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study},
journal={ADVANCES IN THERAPY},
volume={38},
number={1},
pages={350-365},
document_type={Article},
} 

@ARTICLE{
author={Hart Lowell L,Andric Zoran G,...,Radosavljevic Davorin Z,Jovanovic Dragana,...,Samarzija Miroslav,Zaric Bojan,...,(broj koautora 20)},
year={2019},
title={Effect of trilaciclib, a CDK 4/6 inhibitor, on myelosuppression in patients with previously treated extensive-stage small cell lung cancer receiving topotecan.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={37},
number={15},
pages={-},
document_type={Meeting Abstract},
}